MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-24-2026
Country |
 USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.29 B |
Market Cap[1] |
$ 111 B |
EBITDA (LTM) |
$ 7.85 B |
P/E (LTM) |
23.06 |
P/S (LTM) |
3.22 |
EPS (LTM) |
3.78 |
Medtronic is an international medical company that specializes in developing and manufacturing innovative medical technologies. The company was founded in the United States in 1949 and today is a leader in the field of medical technology.
Medtronic offers a wide range of products and services in cardiology, endocrinology, neurology, orthopedics, surgery, and more. Among the company's products are implantable cardiac pacemakers, glucose meters, insulin infusion pumps, pain management systems, deep brain stimulation devices, and much more.
Medtronic is actively engaged in scientific research and development in the field of medicine. As a result, its products are the most effective and safe for patients. The company also provides training and consultations to doctors and medical personnel on the use of its products.
Medtronic has offices and representatives in more than 160 countries around the world, which allows it to provide maximum accessibility of its products and services to patients worldwide. Medtronic is a reliable partner for medical institutions and patients who need innovative solutions to maintain health and life.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | USA |
 |
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market |  China |
 |
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | USA |
 |
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | USA |
 |
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | USA |
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | USA |
 |
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | USA |
 |
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | USA |
 |
IRIDEX Corporation
IRIX
|
$ 1.35 | - | $ 21.8 M | Nasdaq Global Select Market | USA |
 |
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | USA |
 |
Orthofix Medical
OFIX
|
$ 11.72 | -1.26 % | $ 464 M | Nasdaq Global Select Market,SPB |  Curacao |
 |
LENSAR
LNSR
|
$ 5.56 | -8.4 % | $ 64 M | Nasdaq Capital Market | USA |
 |
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | USA |
 |
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | USA |
 |
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | USA |
 |
AxoGen
AXGN
|
$ 32.61 | 2.71 % | $ 1.5 B | Nasdaq Capital Market,SPB | USA |
 |
CONMED Corporation
CNMD
|
$ 36.56 | -0.19 % | $ 1.13 B | NYSE,SPB | USA |
 |
Penumbra
PEN
|
$ 334.17 | -0.41 % | $ 13 B | NYSE,SPB | USA |
 |
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | USA |
 |
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market |  Israel |
 |
Electromed
ELMD
|
$ 24.7 | 0.86 % | $ 209 M | NYSE American | USA |
 |
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market |  Canada |
 |
Insulet Corporation
PODD
|
$ 225.5 | -0.7 % | $ 15.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | USA |
 |
Cytosorbents Corporation
CTSO
|
$ 0.7 | 3.3 % | $ 38.1 M | Nasdaq Capital Market | USA |
 |
Aethlon Medical
AEMD
|
$ 2.16 | -6.09 % | $ 3.37 M | Nasdaq Capital Market | USA |
 |
Profound Medical Corp.
PROF
|
$ 5.15 | -4.63 % | $ 180 M | Nasdaq Global Select Market | Canada |
 |
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | USA |
 |
Quanterix Corporation
QTRX
|
$ 3.82 | -3.05 % | $ 163 M | Nasdaq Global Select Market,SPB | USA |
 |
AdaptHealth Corp.
AHCO
|
$ 11.48 | 10.7 % | $ 1.55 B | Nasdaq Capital Market | USA |
 |
Myomo
MYO
|
$ 0.7 | -1.83 % | $ 29.3 M | NYSE American | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
$ 2.4 | -1.64 % | $ 141 M | Nasdaq Global Select Market | Israel |
 |
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | USA |
 |
EDAP TMS S.A.
EDAP
|
$ 3.91 | 4.83 % | $ 146 M | Nasdaq Global Market |  France |
 |
OrthoPediatrics Corp.
KIDS
|
$ 15.91 | -3.4 % | $ 373 M | Nasdaq Global Select Market,SPB | USA |
 |
Outset Medical
OM
|
$ 3.53 | -2.35 % | $ 53.7 K | Nasdaq Global Select Market | USA |
 |
Inspire Medical Systems
INSP
|
$ 52.07 | -0.17 % | $ 1.53 B | NYSE,SPB | USA |
 |
Sintx Technologies
SINT
|
$ 2.57 | 0.78 % | $ 7.13 M | Nasdaq Capital Market | USA |
 |
Pulmonx Corporation
LUNG
|
$ 1.31 | -5.76 % | $ 53.3 M | Nasdaq Global Select Market | USA |
 |
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | USA |
 |
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | USA |
 |
Sensus Healthcare
SRTS
|
$ 3.96 | -3.65 % | $ 64.7 M | Nasdaq Capital Market | USA |
 |
InspireMD
NSPR
|
$ 1.79 | 3.47 % | $ 115 M | NYSE American | Israel |
 |
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | USA |
 |
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | USA |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.